Chemoinformaics analysis of 4-Hydroxy-2-methylacetophenone
| Molecular Weight | 150.177 | nRot | 1 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 7 |
| Exact Molecular Weight | 150.068 | nRing | 1 |
| Solubility: LogS | -1.419 | nHRing | 0 |
| Solubility: LogP | 1.771 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 23.3019 |
| nHD | 1 | BPOL | 10.9001 |
| QED | 0.621 |
| Synth | 1.808 |
| Natural Product Likeliness | 0.428 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.1 |
| HIA | 0.004 |
| CACO-2 | -4.488 |
| MDCK | 0.0000213 |
| BBB | 0.649 |
| PPB | 0.742091 |
| VDSS | 0.933 |
| FU | 0.25898 |
| CYP1A2-inh | 0.955 |
| CYP1A2-sub | 0.917 |
| CYP2c19-inh | 0.701 |
| CYP2c19-sub | 0.143 |
| CYP2c9-inh | 0.196 |
| CYP2c9-sub | 0.911 |
| CYP2d6-inh | 0.404 |
| CYP2d6-sub | 0.854 |
| CYP3a4-inh | 0.256 |
| CYP3a4-sub | 0.265 |
| CL | 11.676 |
| T12 | 0.871 |
| hERG | 0.025 |
| Ames | 0.12 |
| ROA | 0.108 |
| SkinSen | 0.347 |
| Carcinogencity | 0.556 |
| EI | 0.994 |
| Respiratory | 0.175 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.864329 |